Skip to main content

Serevent Diskus Side Effects

Generic name: salmeterol

Medically reviewed by Last updated on Jul 11, 2022.

Note: This document contains side effect information about salmeterol. Some of the dosage forms listed on this page may not apply to the brand name Serevent Diskus.

For the Consumer

Applies to salmeterol: inhalation powder

Side effects requiring immediate medical attention

Along with its needed effects, salmeterol (the active ingredient contained in Serevent Diskus) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking salmeterol:

More common

  • Cough producing mucus
  • difficulty with breathing
  • headache
  • irritation of the throat
  • runny nose
  • sneezing
  • stuffy nose
  • tightness in the chest

Less common

  • Blistering, burning, crusting, dryness, or flaking of the skin
  • blurred vision
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • chills
  • colds
  • diarrhea
  • dizziness
  • dry mouth
  • fever
  • flushed, dry skin
  • fruit-like breath odor
  • general feeling of discomfort or illness
  • hoarseness
  • increased hunger
  • increased thirst
  • increased urination
  • itching, scaling, severe redness, soreness, or swelling of the skin
  • joint pain
  • loss of appetite
  • muscle aches and pains
  • nausea
  • nervousness
  • noisy breathing
  • pain
  • pain or tenderness around the eyes and cheekbones
  • pounding in the ears
  • shivering
  • skin rash, encrusted, scaly and oozing
  • slow or fast heartbeat
  • sore mouth, tongue, or throat
  • stomach pain
  • sweating
  • swelling
  • trouble with sleeping
  • unexplained weight loss
  • unusual tiredness or weakness
  • vomiting
  • white patches in the mouth or on the tongue

Incidence not known

  • Choking or feeling of choking
  • difficulty swallowing
  • extra heartbeat
  • fainting
  • fast, pounding, or irregular heartbeat or pulse
  • hives or welts
  • mouth irritation
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • slow heartbeat

Get emergency help immediately if any of the following symptoms of overdose occur while taking salmeterol:

Symptoms of overdose

  • Arm, back, or jaw pain
  • confusion
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fainting
  • fast, slow, pounding, or irregular heartbeat or pulse
  • seizures
  • shakiness in the legs, arms, hands, or feet
  • sleeplessness
  • trembling or shaking of the hands or feet

Side effects not requiring immediate medical attention

Some side effects of salmeterol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Anxiety
  • belching
  • bone pain
  • burning, dry, or itching eyes
  • difficulty with moving
  • discharge or excessive tearing
  • eye redness, irritation, or pain
  • headache, severe and throbbing
  • heartburn
  • indigestion
  • mouth or tooth pain
  • muscle cramps, spasm, stiffness, or tightness
  • redness of the skin
  • redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
  • stomach discomfort or upset

For Healthcare Professionals

Applies to salmeterol: inhalation aerosol, inhalation aerosol with adapter, inhalation powder


Very common (10% or more): Musculoskeletal pain (12%)

Common (1% to 10%): Arthralgia, articular rheumatism, muscle cramps and spasm, bone and skeletal pain, muscle pain, muscle stiffness, muscle tightness, muscle rigidity, musculoskeletal inflammation

Frequency not reported: Join pain[Ref]

Nervous system

Very common (10% or more): Headache (up to 14%)

Common (1% to 10%): Dizziness, migraines, tremor

Frequency not reported: Sinus headache, paresthesia[Ref]


Common (1% to 10%): Pallor, hypertension, palpitations

Uncommon (0.1% to 1%): Tachycardia

Very rare (less than 0.01%): Arrhythmias (including atrial fibrillation, supraventricular tachycardia, extrasystoles)

Frequency not reported: Peripheral vasodilation and a compensatory small increase in heart rate[Ref]


Common (1% to 10%): Skin rashes, urticaria, photodermatitis

Frequency not reported: Contact dermatitis, eczema[Ref]


Common (1% to 10%): Gastrointestinal signs and symptoms, nausea, vomiting, candidiasis mouth/throat, dental discomfort and pain, dyspeptic symptoms, gastrointestinal infections, hyposalivation

Frequency not reported: Oral mucosal abnormality[Ref]


Common (1% to 10%): Transient elevation of hepatic enzymes[Ref]


Common (1% to 10%): Hyperglycemia

Rare (less than 0.1%): Hypokalemia[Ref]


Common (1% to 10%): Conjunctivitis, keratitis[Ref]


Common (1% to 10%): Influenza, ear signs and symptoms, edema and swelling

Frequency not reported: Localized aches and pains, pyrexia of unknown origin[Ref]


Common (1% to 10%): Anxiety

Uncommon (0.1% to 1%): Nervousness

Rare (less than 0.1%): Insomnia

Frequency not reported: Sleep disturbances[Ref]


Common (1% to 10%): Nasal/sinus congestion, rhinitis, asthma, tracheitis/bronchitis, pharyngitis, sinusitis, upper respiratory tract infection, cough, throat irritation, lower respiratory signs and symptoms

Very rare (less than 0.01%): Paradoxical bronchospasm, non specific chest pain, oropharyngeal irritation

Frequency not reported: Bronchospasm

Postmarketing reports: Upper airway symptoms of laryngeal spasm, irritation, or swelling such as stridor or choking[Ref]


Very rare (less than 0.01%): Anaphylactic reactions including edema and angioedema, bronchospasm and anaphylactic shock

Frequency not reported: Immediate hypersensitivity reactions

Postmarketing reports: Anaphylaxis[Ref]


1. D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI "Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma." JAMA 271 (1994): 1412-6

2. Kemp JP, Bierman CW, Cocchetto DM "Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring." Ann Allergy 70 (1993): 316-22

3. Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW, et al. "A comparison of salmeterol with albuterol in the treatment of mild-to- moderate asthma." N Engl J Med 327 (1992): 1420-5

4. Meyer JM, Wenzel CL, Kradjan WA "Salmeterol: a novel, long-acting beta 2-agonist." Ann Pharmacother 27 (1993): 1478-87

5. Maconochie JG, Minton NA, Chilton JE, Keene ON "Does tachyphylaxis occur to the non-pulmonary effects of salmeterol?" Br J Clin Pharmacol 37 (1994): 199-204

6. Brogden RN, Faulds D "Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease." Drugs 42 (1991): 895-912

7. Britton MG, Earnshaw JS, Palmer JB "A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group [published erratum appears in Eur Respir J 1993;6(1):150]." Eur Respir J 5 (1992): 1062-7

8. Ullman A, Svedmyr N "Salmeterol comparison with salbutamol in adult asthmatic patients." Thorax 43 (1988): 674-8

9. "Salmeterol." Med Lett Drugs Ther 36 (1994): 37-9

10. "Product Information. Severent (salmeterol)." Glaxo Wellcome, Research Triangle Park, NC.

11. Mann RD, Kubota K, Pearce G, Wilton L "Salmeterol: a study by prescription-event monitoring in a UK cohort of 15,407 patients." J Clin Epidemiol 49 (1996): 247-50

12. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

13. Cerner Multum, Inc. "Australian Product Information." O 0

14. Maconochie JG, Forster JK "Dose-response study with high-dose inhaled salmeterol in healthy subjects." Br J Clin Pharmacol 33 (1992): 342-5

15. Lopezguillen A, Marques L, Lopezllorente MT, Pastor E, Figueras A "Salmeterol-induced vertigo." Eur Respir J 7 (1994): 2089-90

16. Tranfa CME, Pelaia G, Grembiale RD, Naty S, Durante S, Borrello G "Short-term cardiovascular effects of salmeterol." Chest 113 (1998): 1272-6

17. Svedmyr N, Lofdahl CG "The use of beta(2)-adrenoceptor agonists in the treatment of bronchial asthma." Pharmacol Toxicol 78 (1996): 3-11

18. Booth H, Bish R, Walters J, Whitehead F, Walters EH "Salmeterol tachyphylaxis in steroid treated asthmatic subjects." Thorax 51 (1996): 1100-4

19. Wilkinson JR, Roberts JA, Bradding P, Holgate ST, Howarth PH "Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler." BMJ 305 (1992): 931-2

20. Clark CE, Ferguson AD, Siddorn JA "Respiratory arrests in young asthmatics on salmeterol." Respir Med 87 (1993): 227-8

21. Dottorini ML, Tantucci C, Peccini F, Grassi V, Sorbini CA "Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol." Int J Clin Pharmacol Ther 34 (1996): 438-43

22. Hatton MQ, Allen MB, Mellor EJ, Cooke NJ "Salmeterol rash ." Lancet 337 (1991): 1169-70

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.